Literature DB >> 32115910

Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis.

Wei Zhu1, Bo-Lun Zhou1, Li-Juan Rong1, Li Ye1, Hong-Juan Xu1, Yao Zhou1, Xue-Jun Yan1, Wei-Dong Liu1, Bin Zhu1, Lei Wang1, Xing-Jun Jiang1, Cai-Ping Ren1.   

Abstract

Polypyrimidine tract-binding protein 1 (PTBP1) plays an essential role in splicing and is expressed in almost all cell types in humans, unlike the other proteins of the PTBP family. PTBP1 mediates several cellular processes in certain types of cells, including the growth and differentiation of neuronal cells and activation of immune cells. Its function is regulated by various molecules, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA-binding proteins. PTBP1 plays roles in various diseases, particularly in some cancers, including colorectal cancer, renal cell cancer, breast cancer, and glioma. In cancers, it acts mainly as a regulator of glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. The role of PTBP1 in cancer has become a popular research topic in recent years, and this research has contributed greatly to the formulation of a useful therapeutic strategy for cancer. In this review, we summarize recent findings related to PTBP1 and discuss how it regulates the development of cancer cells.

Entities:  

Keywords:  Polypyrimidine tract-binding protein 1 (PTBP1); Alternative splicing; Glycolysis; M2 isoform of pyruvate kinase (PKM2); Cancer

Mesh:

Substances:

Year:  2020        PMID: 32115910      PMCID: PMC7076342          DOI: 10.1631/jzus.B1900422

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  110 in total

1.  Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.

Authors:  Hidekazu Takahashi; Junichi Nishimura; Yoshinori Kagawa; Yoshihiro Kano; Yusuke Takahashi; Xin Wu; Masayuki Hiraki; Atsushi Hamabe; Masamitsu Konno; Naotsugu Haraguchi; Ichiro Takemasa; Tsunekazu Mizushima; Masaru Ishii; Koshi Mimori; Hideshi Ishii; Yuichiro Doki; Masaki Mori; Hirofumi Yamamoto
Journal:  Mol Cancer Ther       Date:  2015-04-22       Impact factor: 6.261

2.  Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.

Authors:  Chune Liu; Zhihong Yang; Jianguo Wu; Li Zhang; Sangmin Lee; Dong-Ju Shin; Melanie Tran; Li Wang
Journal:  Hepatology       Date:  2018-03-25       Impact factor: 17.425

3.  Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2.

Authors:  Niroshika Keppetipola; Shalini Sharma; Qin Li; Douglas L Black
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-02       Impact factor: 8.250

4.  p53 represses c-Myc through induction of the tumor suppressor miR-145.

Authors:  Mohit Sachdeva; Shoumin Zhu; Fangting Wu; Hailong Wu; Vijay Walia; Sumit Kumar; Randolph Elble; Kounosuke Watabe; Yin-Yuan Mo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

5.  PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons.

Authors:  Jonathan P Ling; Resham Chhabra; Jonathan D Merran; Paul M Schaughency; Sarah J Wheelan; Jeffry L Corden; Philip C Wong
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

6.  MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.

Authors:  Koichiro Minami; Kohei Taniguchi; Nobuhiko Sugito; Yuki Kuranaga; Teruo Inamoto; Kiyoshi Takahara; Tomoaki Takai; Yuki Yoshikawa; Satoshi Kiyama; Yukihiro Akao; Haruhito Azuma
Journal:  Oncotarget       Date:  2017-05-16

7.  PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.

Authors:  Athena Georgilis; Sabrina Klotz; Christopher J Hanley; Nicolas Herranz; Benedikt Weirich; Beatriz Morancho; Ana Carolina Leote; Luana D'Artista; Suchira Gallage; Marco Seehawer; Thomas Carroll; Gopuraja Dharmalingam; Keng Boon Wee; Marco Mellone; Joaquim Pombo; Danijela Heide; Ernesto Guccione; Joaquín Arribas; Nuno L Barbosa-Morais; Mathias Heikenwalder; Gareth J Thomas; Lars Zender; Jesús Gil
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

8.  The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators.

Authors:  Miriam Llorian; Clare Gooding; Nicolas Bellora; Martina Hallegger; Adrian Buckroyd; Xiao Wang; Dipen Rajgor; Melis Kayikci; Jack Feltham; Jernej Ule; Eduardo Eyras; Christopher W J Smith
Journal:  Nucleic Acids Res       Date:  2016-06-17       Impact factor: 16.971

9.  Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression.

Authors:  Kohei Taniguchi; Nobuhiko Sugito; Haruka Shinohara; Yuki Kuranaga; Yosuke Inomata; Kazumasa Komura; Kazuhisa Uchiyama; Yukihiro Akao
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

10.  Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development.

Authors:  Jinhua Liu; Yapu Li; Jingyuan Tong; Jie Gao; Qing Guo; Lingling Zhang; Bingrui Wang; Hui Zhao; Hongtao Wang; Erlie Jiang; Ryo Kurita; Yukio Nakamura; Osamu Tanabe; James Douglas Engel; Emery H Bresnick; Jiaxi Zhou; Lihong Shi
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

View more
  13 in total

1.  Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology.

Authors:  Yang Chen; Qian Li; Sisi Ren; Ting Chen; Bingtao Zhai; Jiangxue Cheng; Xiaoyan Shi; Liang Song; Yu Fan; Dongyan Guo
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

Review 2.  Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases.

Authors:  Matilde Contardo; Roberta De Gioia; Delia Gagliardi; Giacomo Pietro Comi; Linda Ottoboni; Monica Nizzardo; Stefania Corti
Journal:  Biomedicines       Date:  2022-02-07

3.  PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.

Authors:  Haiyi Gong; Aimin Jiang; Runyi Jiang; Yao Wang; Dan Zhang; Zhipeng Wu; Jianru Xiao
Journal:  Oxid Med Cell Longev       Date:  2022-05-23       Impact factor: 7.310

4.  CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.

Authors:  Yajuan Zhang; Hongxiu Zhang; Xiaolei Zhang; Bin Liu
Journal:  Dis Markers       Date:  2022-05-24       Impact factor: 3.464

5.  KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a.

Authors:  Quan Zhang; Lei Xu; Jianjun Wang; Xiaoming Zhu; Zeheng Ma; Junfeng Yang; Jiwei Li; Xiangbo Jia; Li Wei
Journal:  Onco Targets Ther       Date:  2021-02-22       Impact factor: 4.147

6.  PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression.

Authors:  Yingji Chen; Ying Ji; Suo Liu; Yicai Liu; Wei Feng; Longyu Jin
Journal:  Cancer Cell Int       Date:  2022-01-11       Impact factor: 5.722

7.  PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability.

Authors:  Canbin Xie; Fei Long; Liang Li; Xiaorong Li; Min Ma; Zhixing Lu; Runliu Wu; Yi Zhang; Lihua Huang; Jing Chou; Ni Gong; Gui Hu; Changwei Lin
Journal:  Cell Death Dis       Date:  2022-02-08       Impact factor: 8.469

8.  HOXA11-AS1 Promotes PD-L1-Mediated Immune Escape and Metastasis of Hypopharyngeal Carcinoma by Facilitating PTBP1 and FOSL1 Association.

Authors:  Zheng Zhou; Qian Liu; Gehou Zhang; Diab Mohammed; Sani Amadou; Guolin Tan; Xiaowei Zhang
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

9.  Perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and DNA methylation in newborn dried blood spots in the Upstate KIDS cohort.

Authors:  Sonia L Robinson; Xuehuo Zeng; Weihua Guan; Rajeshwari Sundaram; Pauline Mendola; Diane L Putnick; Robert A Waterland; Chathura J Gunasekara; Kurunthachalam Kannan; Chongjing Gao; Erin M Bell; Edwina H Yeung
Journal:  Environ Res       Date:  2020-12-30       Impact factor: 6.498

Review 10.  PTBP1-targeting microRNAs regulate cancer-specific energy metabolism through the modulation of PKM1/M2 splicing.

Authors:  Kohei Taniguchi; Kazuhisa Uchiyama; Yukihiro Akao
Journal:  Cancer Sci       Date:  2020-11-04       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.